Overexpression of ZNF703 in MCF7 luminal BC cells induced activation of the AKT/MTOR signaling pathway, downregulation of ERα, and reduction of the tamoxifen’s antitumor effect. The gene discussed is ZNF703; the disease is breast cancer.